Home Tags Pharmaceutical
A cancer-drug developer’s stock just surged more than 100% after Merck agreed to a multi-billion-dollar takeover
Merck offered $20 per share in the all-cash bid, more than double ArQule's Friday closing price. The deal is expected to close in early 2020.
The Cambridge-based drugmaker posted promising trial results for the key antidepressant earlier this year.
Johnson & Johnson climbs after settling two opioid epidemic lawsuits, allowing it to avoid an upcoming federal trial
The pharmaceutical giant paid $20.4 million to settle the two Ohio opioid lawsuits. J&J said the settlement includes no admission of liability.
"The opiate litigation storm is speeding up," Trucchio wrote. He says court rulings could signal further losses for the company.
GSK has already issued cease and desist orders to several entities in Malaysia.
Amgen will buy a blockbuster psoriasis drug for $13.4 billion — and it’s part of a plan to get Celgene’s mega-merger with Bristol-My...
Celgene agreed to a $74 billion merger with Bristol-Myers Squibb back in January 2019, and it's still awaiting regulatory approval.
A Walgreens spokesperson told Business Insider that six million customers visit its locations every single day.
Merck climbs after announcing massive growth for its top cancer drug, which is now on pace to generate $10 billion a year
Keytruda sales rose 58%, making $2.63 billion in the second quarter. The drug's success pushes Merck ahead of its rival Bristol-Myers Squibb.
CVS and other drug-plan providers surge after the Trump administration scraps a key part of its push to lower prices
The plan would have banned pharmacy benefit managers from profiting on deals cut between drugmakers and insurance plans.
A new study finds certain antidepressants and antipsychotic drugs may increase your risk of dementia, and you may not even know you’re on them
Anticholinergic drugs work by blocking a specific brain chemical involved in muscle contractions. Their risks may be greater in middle age and beyond.